The study evaluated an online writing intervention (WriteforIBD) to help individuals with inflammatory bowel disease (IBD) manage distress during the COVID-19 pandemic.
Nineteen adults participated in a randomized controlled trial, with high retention rates and 84.2% satisfaction reported; both groups showed improvement in distress levels.
The WriteforIBD group maintained resilience levels, while the control group experienced a decline, suggesting that online expressive writing may be a beneficial approach for those with IBD.